세계의 빈혈 치료제 시장 보고서(2025년)

Anemia drugs are used to treat low levels of red blood cells (RBCs) or hemoglobin in the blood. These medications enhance oxygen transport throughout the body and help alleviate fatigue by addressing the root causes of anemia, such as iron deficiency, chronic illnesses, or kidney problems.

The main categories of anemia drugs include dietary supplements and medications. Dietary supplements are oral products that provide essential nutrients like iron, folic acid, or vitamin B12 to help manage or prevent anemia. Treatment approaches consist of oral iron therapy, parenteral iron therapy, red blood cell transfusions, and other supportive care options. The different types of anemia treated include iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia, pernicious anemia, and other forms. These drugs are distributed through hospital pharmacies, online pharmacies, and retail pharmacies. The primary end-users include clinics, healthcare facilities, and home healthcare providers.

The anemia drugs market research report is one of a series of new reports from The Business Research Company that provides anemia drugs market statistics, including anemia drugs industry global market size, regional shares, competitors with an anemia drugs market share, anemia drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the anemia drugs industry. This anemia drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anemia drugs market size has grown strongly in recent years. It will grow from $14.72 billion in 2024 to $15.92 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to a higher prevalence of chronic diseases, growing awareness of iron deficiency anemia, an expanding elderly population, improved healthcare access in developing regions, and increasing demand for targeted treatments.

The anemia drugs market size is expected to see strong growth in the next few years. It will grow to $21.53 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth in the forecast period is driven by greater adoption of personalized medicine, increased healthcare spending in emerging markets, a rise in clinical trials focused on anemia treatments, the growing global prevalence of anemia, and a stronger emphasis on patient-centered drug development. Key trends during this period include progress in gene therapies for anemia, development of advanced delivery systems for iron supplements, innovations in erythropoiesis-stimulating agents, enhanced diagnostic tools for detecting anemia, and new advancements in oral anemia medications.

The growing emphasis on personalized medicine is expected to drive the expansion of the anemia drugs market moving forward. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual's genetic makeup, lifestyle, and environment. This increased focus is largely due to advancements in genomic sequencing, which enable more accurate identification of genetic variations linked to diseases and treatment responses. Personalized medicine supports the development of anemia drugs by allowing treatments to be tailored according to individual genetic profiles, thereby enhancing drug effectiveness and reducing adverse effects for improved patient outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases in 2023, a substantial rise from 6 approvals in 2022. Thus, the rising focus on personalized medicine is contributing to the growth of the anemia drugs market.

Key companies in the anemia drugs market are concentrating on innovative drug development, such as oral HIF-PHI (hypoxia-inducible factor prolyl hydroxylase inhibitors), which aim to improve iron metabolism and boost red blood cell production for more effective anemia therapies. Oral HIF-PHI medications inhibit prolyl hydroxylase enzymes that regulate the hypoxia-inducible factor (HIF) pathway. For instance, in February 2023, GSK plc, a UK-based pharmaceutical company, introduced Jesduvroq, a treatment designed to enhance red blood cell production and treat anemia in adult patients with chronic kidney disease. This advanced anemia drug improves iron metabolism and red blood cell production while supporting personalized therapy approaches. Jesduvroq is highly effective at increasing red blood cell production and managing anemia in chronic kidney disease patients by optimizing iron metabolism for better therapeutic results.

In May 2023, Akebia Therapeutics, a U.S.-based biopharmaceutical company, partnered with Medice Arzneimittel Putter GmbH & Co. KG to commercialize Vafseo for anemia treatment in Europe and Australia. Through this collaboration, Akebia Therapeutics and Medice Arzneimittel Putter aim to promote sustainable growth and improve the accessibility of Vafseo by expanding its availability and fostering innovation. Medice Arzneimittel Putter GmbH & Co. KG is a Germany-based pharmaceutical company specializing in anemia treatments and prescription medicines.

Major players in the anemia drugs market are Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Fresenius SE & Co. KGaA, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Biocon Limited, Akebia Therapeutics Inc., Apellis Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, Covis Pharma GmbH, AdvaCare Pharma LLC, Regen Biopharma Inc., BioLineRx Ltd., Bluebird Bio Inc.

North America was the largest region in the anemia drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anemia drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anemia drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anemia drugs market consists of sales of androgens, hydroxyurea, luspatercept and sotatercept. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anemia Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anemia drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anemia drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anemia drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Dietary Supplements; Medicines
• 2) By Therapy Type: Oral Iron Therapy; Red Blood Cell Transfusion; Parental Iron Therapy; Other Therapy Types
• 3) By Anemia Type: Iron Deficiency Anemia; Sickle Cell Anemia; Aplastic Anemia; Hemolytic Anemia; Pernicious Anemia; Others Anemia Type
• 4) By Distribution Channel: Hospitals Pharmacy; Online Pharmacy; Pharmacy
• 5) By End-User: Clinic; Healthcare; Home Healthcare
• Subsegments:
• 1) By Dietary Supplements: Iron Supplements; Vitamin B12 Supplements; Folic Acid Supplements; Multivitamin And Mineral Supplements
• 2) By Medicines: Erythropoiesis-Stimulating Agents (ESAs); Iron Chelating Agents; Corticosteroids; Immunosuppressants; Luspatercept And Related Agents
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer Aktiengesellschaft; Sanofi S.A.; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anemia Drugs Market Characteristics

3. Anemia Drugs Market Trends And Strategies

4. Anemia Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anemia Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anemia Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anemia Drugs Market Growth Rate Analysis
• 5.4. Global Anemia Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anemia Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anemia Drugs Total Addressable Market (TAM)

6. Anemia Drugs Market Segmentation

• 6.1. Global Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Supplements
• Medicines
• 6.2. Global Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Iron Therapy
• Red Blood Cell Transfusion
• Parental Iron Therapy
• Other Therapy Types
• 6.3. Global Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iron Deficiency Anemia
• Sickle Cell Anemia
• Aplastic Anemia
• Hemolytic Anemia
• Pernicious Anemia
• Others Anemia Type
• 6.4. Global Anemia Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinic
• Healthcare
• Home Healthcare
• 6.5. Global Anemia Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacy
• Online Pharmacy
• Pharmacy
• 6.6. Global Anemia Drugs Market, Sub-Segmentation Of Dietary Supplements,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Iron Supplements
• Vitamin B12 Supplements
• Folic Acid Supplements
• Multivitamin and Mineral Supplements
• 6.7. Global Anemia Drugs Market, Sub-Segmentation Of Medicines,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Erythropoiesis-Stimulating Agents (ESAs)
• Iron Chelating Agents
• Corticosteroids
• Immunosuppressants
• Luspatercept And Related Agents

7. Anemia Drugs Market Regional And Country Analysis

• 7.1. Global Anemia Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anemia Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anemia Drugs Market

• 8.1. Asia-Pacific Anemia Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anemia Drugs Market

• 9.1. China Anemia Drugs Market Overview
• 9.2. China Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anemia Drugs Market

• 10.1. India Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anemia Drugs Market

• 11.1. Japan Anemia Drugs Market Overview
• 11.2. Japan Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anemia Drugs Market

• 12.1. Australia Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anemia Drugs Market

• 13.1. Indonesia Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anemia Drugs Market

• 14.1. South Korea Anemia Drugs Market Overview
• 14.2. South Korea Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anemia Drugs Market

• 15.1. Western Europe Anemia Drugs Market Overview
• 15.2. Western Europe Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anemia Drugs Market

• 16.1. UK Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anemia Drugs Market

• 17.1. Germany Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anemia Drugs Market

• 18.1. France Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anemia Drugs Market

• 19.1. Italy Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anemia Drugs Market

• 20.1. Spain Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anemia Drugs Market

• 21.1. Eastern Europe Anemia Drugs Market Overview
• 21.2. Eastern Europe Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anemia Drugs Market

• 22.1. Russia Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anemia Drugs Market

• 23.1. North America Anemia Drugs Market Overview
• 23.2. North America Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anemia Drugs Market

• 24.1. USA Anemia Drugs Market Overview
• 24.2. USA Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anemia Drugs Market

• 25.1. Canada Anemia Drugs Market Overview
• 25.2. Canada Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anemia Drugs Market

• 26.1. South America Anemia Drugs Market Overview
• 26.2. South America Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anemia Drugs Market

• 27.1. Brazil Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anemia Drugs Market

• 28.1. Middle East Anemia Drugs Market Overview
• 28.2. Middle East Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anemia Drugs Market

• 29.1. Africa Anemia Drugs Market Overview
• 29.2. Africa Anemia Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anemia Drugs Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anemia Drugs Market, Segmentation By Anemia Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anemia Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anemia Drugs Market Competitive Landscape
• 30.2. Anemia Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Anemia Drugs Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceutical Company Limited
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc.
• 31.4. Fresenius SE & Co. KGaA
• 31.5. Daiichi Sankyo Company Limited
• 31.6. Sun Pharmaceutical Industries Ltd.
• 31.7. Biocon Limited
• 31.8. Akebia Therapeutics Inc.
• 31.9. Apellis Pharmaceuticals Inc.
• 31.10. Rockwell Medical Inc.
• 31.11. Pharmacosmos A/S
• 31.12. Shield Therapeutics plc
• 31.13. Covis Pharma GmbH
• 31.14. AdvaCare Pharma LLC
• 31.15. Regen Biopharma Inc.

32. Global Anemia Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anemia Drugs Market

34. Recent Developments In The Anemia Drugs Market

35. Anemia Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Anemia Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anemia Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anemia Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer